BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Oliveira Magalhães Mourão A, Braga Gomes K, Afonso Reis E, Pedra de Souza R, de Freitas Campos EI, Dias Ribeiro D, da Costa Rocha MO, Parreiras Martins MA. Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects. Pharmacogenomics J 2020;20:104-13. [PMID: 31395958 DOI: 10.1038/s41397-019-0091-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Qian M, Zhao H, Lou Y, Wang J, Wang S, Wang Z, Ou H, Li J, Yang F, Bai L, Lv H, Peng X, Chen X, Yang X. Establishment of prediction algorithm for the Honghe minority group based on warfarin maintenance dose. Pharmacogenomics 2022. [PMID: 35880564 DOI: 10.2217/pgs-2022-0038] [Reference Citation Analysis]
2 Hirata TDC, Dagli-Hernandez C, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Mol Diagn Ther 2021. [PMID: 34357562 DOI: 10.1007/s40291-021-00549-z] [Reference Citation Analysis]
3 Park S, Jang I. Factors Affecting Medication Adherence in Patients with Mechanical Heart Valves Taking Warfarin: The Role of Knowledge on Warfarin, Medication Belief, Depression, and Self-Efficacy. Int J Environ Res Public Health 2021;18:5214. [PMID: 34068932 DOI: 10.3390/ijerph18105214] [Reference Citation Analysis]
4 Costa Viana C, da Silva Praxedes MF, Freitas Nunes de Sousa WJ, Bartolazzi F, Sousa Vianna M, Padilha da Silva JL, Parreiras Martins MA. Sex-influence on the time in therapeutic range (TTR) during oral anticoagulation with coumarin derivatives: Systematic review and meta-analysis. Br J Clin Pharmacol 2021. [PMID: 33973668 DOI: 10.1111/bcp.14892] [Reference Citation Analysis]
5 Viana CC, Praxedes MFDS, de Sousa WJFN, Bartolazzi F, Vianna MS, Silva JLPD, Martins MAP. Influence of sex-based differences on oral anticoagulation control in patients taking coumarin derivatives: a systematic review protocol. JBI Evidence Synthesis 2021;19:477-83. [DOI: 10.11124/jbies-20-00168] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Haga SB. Individualizing pharmacogenomic test results in the context of the microbiome. Per Med 2020;17:459-68. [PMID: 33026284 DOI: 10.2217/pme-2020-0077] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhu Y, Xu C, Liu J. Randomized controlled trial of genotype-guided warfarin anticoagulation in Chinese elderly patients with nonvalvular atrial fibrillation. J Clin Pharm Ther 2020;45:1466-73. [PMID: 32710457 DOI: 10.1111/jcpt.13218] [Reference Citation Analysis]
8 Al Ammari M, AlBalwi M, Sultana K, Alabdulkareem IB, Almuzzaini B, Almakhlafi NS, Aldrees M, Alghamdi J. The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort. Sci Rep 2020;10:11613. [PMID: 32669629 DOI: 10.1038/s41598-020-68519-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Lauschke VM, Ingelman-Sundberg M. Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation. NPJ Genom Med 2020;5:9. [PMID: 32194983 DOI: 10.1038/s41525-020-0119-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]